immunotherapy
209 projects
HEIndividual fellowship2025–2027Italy
iINGUT · immunotherapy on an INtegrated GUt microbiome and Tumor on-chip.
2 partners
HEDoctoral network2025–2029Germany
T-RAFIC · Training network for tracking and controlling therapeutic immune cells in cancer
28 partners · 9 countries
HEIndividual fellowship2025–2027Spain
SMART-NHL · Studying the Microenvironment And Related Targets in Non-Hodgkin's Lymphoma
HEIndividual fellowship2025–2026Portugal
MultiTheranostic · Theranostic magnetic nano-based codelivery system for boosting cancer immunotherapy
2 partners · 2 countries
HEIndividual fellowship2025–2027Sweden
MAPiT · Dissolving microneedle array patch-based psoriatic immunotherapy using nanoparticles
2 partners
HEIndividual fellowship2025–2027Germany
UBImmune · Identification of novel therapeutic approaches to target the immune checkpoint protein B7H3
HEIndividual fellowship2025–2027Spain
DEXTER · Development of EXtracellular-based artificial bio-nanoparticles: a novel Targeted vector with high potential in cancer ThERapy
HEIndividual fellowship2025–2027Spain
CARLY · Development and characterization of a novel CAR T-cell therapy for NHL
2 partners
HEIndividual fellowship2025–2027Belgium
noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs
2 partners · 2 countries
HEIndividual fellowship2025–2027Belgium
DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
HEDoctoral network2024–2028Netherlands
Mac4Me · Macrophage Targets for Metastatic Treatment
26 partners · 13 countries
HEDoctoral network2024–2028Netherlands
MIRACLE · Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
22 partners · 8 countries
HEIndividual fellowship2024–2026Netherlands
SupraCODE · Spatial control of antigen-encoded supramolecular copolymers for robust T-cell activation against cancer
HEIndividual fellowship2024–2026France
HICoNK · Explore the role of NK cells in post-treatment control of HIV-1 infection: impact of genetic background and early treatment initiation
HEIndividual fellowship2024–2027Netherlands
BEAT B-cell Lymphoma · Biomarkers of Effective CART19 Assessed in the Tissue Microenvironment
2 partners · 2 countries
HEIndividual fellowship2024–2027Germany
MetaboTract · Improving cellular cancer immunotherapy using chemotactic metabolite receptors
HEIndividual fellowship2024–2025Spain
NIR-NanoCAR · Near-Infrared Photothermal Nano-CAR Immunotherapy mediated by engineered exosomes targeted to pancreatic cancer with mutated KRAS
2 partners · 2 countries
HEIndividual fellowship2024–2025France
NanoImmunoRT · Synergizing enhanced radiotherapy with tumor-associated macrophages-targeted immunotherapy in glioblastoma with multimodal therapeutic nanoparticles
HEIndividual fellowship2024–2027Austria
immunoMet · Deciphering immune evasion mechanisms of metastatic cancer cells using CRISPRa-inducible reporters
HEIndividual fellowship2024–2026Luxembourg
INCEPTOR · Investigate the mode of action ofInvestigate the mode of action of beta-carboline derivative Harmine on increasing MHC-I expression and potentiating the Immune Checkpoint Blockade cancer immunotherapy
HEIndividual fellowship2024–2026Sweden
BiorthoCat-Immuno · Biorthogonal Catalytic Scaffold for in situ Personalized Cancer Chemo-Immunotherapy
HEIndividual fellowship2023–2025France
TABANK · Targeting B cell Activation driven by Natural Killer cells
HEIndividual fellowship2023–2026Belgium
IMEIV · Effect of insulin and feed/fast cycle on vaccine efficacy and safety.
HEIndividual fellowship2023–2025Ireland